Market Overview

CORRECTION: Sagent Pharmaceuticals, Inc. Reports Q3 EPS of $0.10 vs $(0.02) Est; Revenue of $60.80M vs $60.82M Est

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Earnings News

 

Related Articles (SGNT)